Objective To investigate the effect of Bushen Qianggu Fang on serum TRACP5b expression in patients with primary osteoporosis. Methods A total of 60 patients with primary osteoporosis were selected from January 2015 to July 2017. The patients were divided into two groups: the treatment group and the control group. The treatment group was treated with oral Calcium D tablet + Bushen Qianggu fang treatment. The control group was treated with oral Erqi D film and Fu Shanmei tablet for 3 months. TCM symptom score, bone mineral density, pain score, fracture risk assessment, TRACP5b. Results ①After 3 months of treatment, the symptoms in the treatment group were significantly improved compared with the control group (P<0.05). ② Followed up for 6 months,the bone mineral density of the treatment group was significantly improved compared with the control group (P<0.05). After 2 months and 3 months, the pain score and the risk assessment of the treatment group and the serum TRACP5b in the treatment group were significantly improved compared with the control group (P<0.05) .Conclusion Bushen Qiangguang Fang can effectively relieve the clinical symptoms of patients, Inhibit excessive bone turnover, so that bone metabolism to achieve a new balance, improve bone mass.
Bushen Qianggu fangprimary osteoporosistartrate-resistant acid phosphatase 5 b
NETL
NSTL
维普
万方数据
